Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Confirmed diagnosis of stage IV NSCLC.
Have progressed during or after platinum-based chemotherapy for advanced disease.
Have not received prior treatment with docetaxel.
Have availability of adequate formalin-fixed paraffin-embedded (FFPE) tumor derived material.
Have adequate organ function including hematology, renal, and liver.
Have good performance score (0-1).
Have measurable disease per RECIST 1.1.
Agree to use a reliable medically approved method of birth control.
You may not be if
Have received prior treatment with any cyclin dependent kinase (CDK) 4 and 6 inhibitor or participated in a clinical trial with a CDK 4 and 6 inhibitor and the treatment administered is not known.
Are currently receiving treatment in a clinical trial involving an investigational product or non-approved use of a drug or device.
Have the presence of unstable central nervous system (CNS) metastasis.
Have had major surgery (excluding biopsy) \< 28 days of the initial dose of study drug.
Clareo Health | A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer
